Commission Implementing Regulation (EU) 2020/1093 of 24 July 2020 amending Implementing Regulation (EU) No 686/2012 allocating to Member States, for the purposes of the renewal procedure, the evaluation of active substances whose approval expires between 31 March 2025 and 27 December 2028 (Text with EEA relevance)

• CELEX: Implementing Regulation (EU) 2020/1093
• Articles: 3

Article 1

Implementing Regulation (EU) No 686/2012 is amended in accordance with the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the third day following that of its publication in the Official Journal of the European Union .

Schedules & Appendices

ANNEX

ANNEX

The Annex to Implementing Regulation (EU) No 686/2012 is amended as follows:

The following Part D is added:

‘PART D

Allocation of the evaluation of active substances whose approval expires between 31 March 2025 and 27 December 2028

Active substance

Rapporteur Member State

Co-rapporteur Member State

Alpha-cypermethrin

FR

AT

Bacillus amyloliquefaciens subsp. plantarum strain D747

NL

SK

Bacillus amyloliquefaciens strain MBI 600

NL

SK

Beauveria bassiana strain NPP111B005

BE

RO

Beauveria bassiana strain 147

BE

RO

Bentazone

PL

EL

Bordeaux mixture

IT

PL

Chromafenozide

CZ

MT

Copper hydroxide

IT

PL

Copper oxide

IT

PL

Copper oxychloride

IT

PL

Cyantraniliprole

ES

FI

Fenpicoxamid

SE

BG

Flupyradifurone

EL

PL

Gamma-cyhalothrin

DE

ES

Halauxifen-methyl

HU

SE

Isofetamid

PT

IE

Mandestrobin

SE

NO

Meptyldinocap

HR

DE

Methoxyfenozide

FR

HU

Metschnikowia fructicola strain NRRL Y-27328

NL

HR

Oxathiapiprolin

NO

CZ

Pinoxaden

FI

BE

Propyzamide

DK

DE

Rescalure

IE

PT

Sulfoxaflor

AT

ES

Terpenoid blend QRD 460

FR

DK

Tribasic copper sulphate

IT

PL’